UroGen Pharma(URGN) - 2018 Q4 - Earnings Call Transcript

UroGen Pharma (NASDAQ:URGN) Q4 2018 Earnings Conference Call February 28, 2019 8:30 AM ET Company Participants Kate Bechtold - Director, Corporate Communications and Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - Chief Financial Officer Conference Call Participants Ram Selvaraju - H. C. Wainwright Boris Peaker - Cowen Leland Gershell - Oppenheimer Chris Howerton - Jefferies Operator Good morning, ladies and gentlemen. Thank ...